HD-OPM Archive
Hashtags

#ldldementia

20 posts

High LDL does not protect the brain: 2024 Lancet Commission lists LDL as top dementia risk

Dec 15, 2024 · Louis Nervegna ♥ 18 · 💬 38 Brain health & dementia

Louis counters the claim that high blood LDL protects against dementia. The 2024 Lancet Commission lists LDL cholesterol as the biggest modifiable dementia risk factor, accounting for 7% of cases among 14 factors that together account for 45%. He adds circulating cholesterol does not cross the blood-brain barrier; the brain makes its own.

Only lipophilic statins like atorvastatin enter the brain; PCSK9 drugs and ezetimibe don't

Oct 18, 2025 · Louis Nervegna ♥ 25 · 💬 10 Brain health & dementia

Louis explains the blood-brain barrier and cholesterol: the brain makes its own cholesterol separately from blood, so non-statin LDL drugs and hydrophilic statins like rosuvastatin have little brain effect. Lipophilic statins do enter the brain, with promising observational data against Alzheimer's, and a 20,000-person atorvastatin trial is under way. Two prior trials showed statins do not worsen existing Alzheimer's, and midlife high LDL is a leading modifiable dementia risk (2024 Lancet Commission, about 7% of US cases per Louis).

Boston Heart's desmosterol test is likely a waste of money, argues Louis

Jan 15, 2024 · Louis Nervegna ♥ 13 · 💬 15 Risk assessment & lab tests

Louis critiques the desmosterol blood test, a marker of cholesterol production marketed for predicting statin response and Alzheimer's risk. He argues statin response can simply be checked by trying a statin, and that in healthy people high (not low) desmosterol is associated with higher dementia risk, so claims that statins raise Alzheimer's risk via lowering desmosterol are backwards. Even the test maker's material says lower desmosterol is optimal.

PREVENTABLE: 20,000-person trial of atorvastatin 40 mg to prevent dementia over age 75

Jun 23, 2025 · Louis Nervegna ♥ 16 · 💬 5 Statins

Louis describes the ongoing PREVENTABLE trial, which randomizes about 20,000 community-dwelling adults aged 75+ to atorvastatin 40 mg or placebo to test whether statins prevent dementia. Atorvastatin was chosen because it is lipophilic and crosses the blood-brain barrier; the trial began in 2020 and is still recruiting.

News report: statins may help slow Alzheimer's disease

Jun 12, 2025 · Louis Nervegna ♥ 13 · 💬 4 Statins

Louis shares a Brighter Side of News report that statins might offer a benefit beyond heart health by slowing Alzheimer's disease, calling it the latest of many studies showing this. No data or trial details are given in the post.